✦ LIBER ✦

Acute megakaryoblastic leukemia in children and adolescents, excluding Down's syndrome: improved outcome with intensified induction treatment

✍ Scribed by Reinhardt, D; Diekamp, S; Langebrake, C; Ritter, J; Stary, J; Dworzak, M; Schrauder, A; Zimmermann, M; Fleischhack, G; Ludwig, W-D

Book ID: 110056337
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 73 KB
Volume: 19
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2403815

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Distinctive Multidrug Sensitivity and Ou

Distinctive Multidrug Sensitivity and Outcome of Acute Erythroblastic and Megakaryoblastic Leukemia in Children With Down Syndrome

✍ Sayuri Yamada; Teruaki Hongo; Shuichi Okada; Chieko Watanabe; Yuji Fujii; Hiroki 📂 Article 📅 2001 🏛 Carden Jennings Publishing 🌐 English ⚖ 94 KB

Janus kinase mutations in the developmen

Janus kinase mutations in the development of acute megakaryoblastic leukemia in children with and without Down's syndrome

✍ Klusmann, J H; Reinhardt, D; Hasle, H; Kaspers, G J; Creutzig, U; Hahlen, K; van 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 191 KB

Clinical characteristics and treatment o

Clinical characteristics and treatment outcome of children with acute lymphocytic leukemia and down's syndrome. A pediatric oncology group study

✍ Abdelsalam H. Ragab; Aly Abdel-Mageed; Jonathan J. Shuster; Lawrence S. Frankel; 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 683 KB

Of 2947 children with acute lymphocytic leukemia (ALL), treated during three consecutive studies of the Pediatric Oncology Group (1974-1986), 52 (1.8%) had Down's Syndrome (DS). Comparison of clinical and laboratory characteristics showed no significant differences in leukocyte count, racial distrib

Prognostic factors in children and adole

Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study 8821

✍ Chang, M; Raimondi, S C; Ravindranath, Y; Carroll, A J; Camitta, B; Gresik, M V; 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 106 KB

Cellular cytotoxic drug sensitivity in c

Cellular cytotoxic drug sensitivity in children with acute leukemia and Down’s syndrome: an explanation to differences in clinical outcome?

✍ Frost, B-M; Gustafsson, G; Larsson, R; Nygren, P; Lönnerholm, G 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 73 KB

Reproductive history, infertility treatm

Reproductive history, infertility treatment, and the risk of acute leukemia in children with down syndrome : A Report From the Children's Oncology Group

✍ Susan E. Puumala; Julie A. Ross; Andrew F. Olshan; Leslie L. Robison; Franklin O 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 2 views

## Abstract ## BACKGROUND. Children with Down syndrome (DS) have from 10 to 20 times the risk of developing acute leukemia than the general pediatric population. There is mixed evidence for associations between reproductive history or infertility and acute leukemia among children without DS. ## M